Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma active vitamin D concentration in low birthweight infants with rickets and its response to vitamin D treatment.

Literature DB >> 6973954

Plasma active vitamin D concentration in low birthweight infants with rickets and its response to vitamin D treatment.

Y Seino, T Ishii, T Shimotsuji, M Ishida, H Yabuuchi.

Abstract

Impairment of 25-hydroxylation may be a cause of rickets in infants of low birthweight, weighing between 2000 and 2500 g. In addition there may be impairment of 1 alpha-hydroxylation in infants weighing less than 2000 g. Our data show that a supplementary dose of vitamin D2 of at least 500 IU daily is a reasonable regimen for infants who weighed between 2000 and 2500 g at birth. However for infants who weighed less than 2000 g with a gestation of under 38 weeks, administration of 1 alpha-OHD3 may be more effective in preventing rickets.

Entities: Chemical Species

Mesh：

Substances：

Year: 1981 PMID： 6973954 PMCID： PMC1627260 DOI： 10.1136/adc.56.8.628

Source DB: PubMed Journal: Arch Dis Child ISSN： 0003-9888 Impact factor: 3.791

13 in total

1. Perinatal vitamin D metabolism. II. Serial 25-hydroxyvitamin D concentrations in sera of term and premature infants.

Authors: L S Hillman; J G Haddad
Journal: J Pediatr Date: 1975-06 Impact factor: 4.406

2. Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver.

Authors: M Fukushima; Y Suzuki; Y Toira; I Matsunaga; K Ochi; H Nagano
Journal: Biochem Biophys Res Commun Date: 1975-09-16 Impact factor: 3.575

3. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.

Authors: S Balsan; M Garabedian; R Sorgniard; M F Holick; H F Deluca
Journal: Pediatr Res Date: 1975-07 Impact factor: 3.756

Plasma active vitamin D concentration in low birthweight infants with rickets and its response to vitamin D treatment.

1. Perinatal vitamin D metabolism. II. Serial 25-hydroxyvitamin D concentrations in sera of term and premature infants.

2. Metabolism of 1alpha-hydroxyvitamin D3 to 1alpha, 25-dihydroxyvitamin D3 in perfused rat liver.

3. 1,25-dihydroxyvitamin D3 and 1, alpha-hydroxyvitamin D3 in children: biologic and therapeutic effects in nutritional rickets and different types of vitamin D resistance.

4. Human perinatal vitamin D metabolism. I. 25-Hydroxyvitamin D in maternal and cord blood.

5. 25-Hydroxyvitamin D. Plasma levels in mothers and their premature infants with neonatal hypocalcemia.

6. Neonatal mortality rate: relationship to birth weight and gestational age.

7. Iatrogenic rickets in low-birth-weight infants.

8. Serum 25-hydroxyvitamin D in infantile rickets.

9. A competitive protein binding assay for plasma 25-hydroxyvitamin D3 in normal children.

10. Plasma 1,25-dihydroxyvitamin D concentrations in cords, newborns, infants, and children.

Review 1. Nutritional aspects of metabolic bone disease in the newborn.

2. Bone mineral content and body size 65 to 100 weeks' postconception in preterm and full term infants.

3. Bone cortical mass in newborn infants: a comparison between standards in the femur and humerus.

4. Supplementary vitamin D in infancy and childhood.

5. Metabolic bone disease in preterm infants.

6. Plasma 25-hydroxyvitamin D and rickets in infants of extremely low birthweight.

7. Hypophosphataemic rickets in the preterm infant; hypocalcaemia after calcium and phosphorus supplementation.

8. Serum 1,25-dihydroxyvitamin D concentrations in premature infants: preliminary results.

9. Plasma ionised calcium in preterm infants: comparison with adults.

10. Oral administration of active vitamin D metabolites to low birthweight infants.